Sandrine Faivre

机构：Inserm, Université Paris Cité, Saint Louis University Hospital, Assistance Publique – Hôpitaux de Paris, Centre de Recherche sur l'Inflammation, Hôpital Saint-Louis · ORCID：0000-0002-1590-485X

发表论文 504 篇 · 总被引 21119 次 · h-index 69

代表论文

• Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights (2024 · Human Pathology · 被引 10)
• Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study (2025 · Targeted Oncology · 被引 8)
• Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence (2024 · JCO Precision Oncology · 被引 8)
• Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN ‐ CK GERCOR Phase II Trial (2025 · Liver International · 被引 6)
• Strategies for early detection and detailed characterization of oral lesions and head and neck squamous cell carcinoma in Fanconi anemia patients (2025 · Cancer Letters · 被引 4)
• Référentiel national de traitement des carcinomes épidermoïdes des voies aérodigestives supérieures – Principes généraux de traitement (2024 · Bulletin du Cancer · 被引 2)